87 related articles for article (PubMed ID: 7543572)
21. Chronic treatment with neuroleptics alters neutral endopeptidase 24.11 activity in rat brain regions.
Konkoy CS; Oakes MG; Davis TP
Peptides; 1993; 14(5):1017-20. PubMed ID: 7904340
[TBL] [Abstract][Full Text] [Related]
22. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
23. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
Mijnster MJ; Schotte A; Docter GJ; Voorn P
Synapse; 1998 Apr; 28(4):302-12. PubMed ID: 9517839
[TBL] [Abstract][Full Text] [Related]
24. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
25. Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain.
Kinkead B; Shahid S; Owens MJ; Nemeroff CB
J Pharmacol Exp Ther; 2000 Oct; 295(1):67-73. PubMed ID: 10991962
[TBL] [Abstract][Full Text] [Related]
26. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
27. Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.
Janicki P; Lypko A; Szczudlik A; Libich J
Pol J Pharmacol Pharm; 1981; 33(5):499-502. PubMed ID: 6174959
[TBL] [Abstract][Full Text] [Related]
28. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
29. Ontogeny of the effect of antipsychotic drug treatment on neurotensin concentrations in the rat brain.
Kinkead B; Owens MJ; Nemeroff CB
Synapse; 1995 Jul; 20(3):244-8. PubMed ID: 7570356
[TBL] [Abstract][Full Text] [Related]
30. Sensitization to amphetamine occurs simultaneously at immune level and in met-enkephalin of the nucleus accumbens and spleen: an involved NMDA glutamatergic mechanism.
Assis MA; Hansen C; Lux-Lantos V; Cancela LM
Brain Behav Immun; 2009 May; 23(4):464-73. PubMed ID: 19486656
[TBL] [Abstract][Full Text] [Related]
31. Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment.
Dawson NM; Hamid EH; Egan MF; Meredith GE
Synapse; 2001 Jan; 39(1):70-81. PubMed ID: 11071712
[TBL] [Abstract][Full Text] [Related]
32. Striatal neuropeptide levels in Parkinson's disease patients.
Fernandez A; de Ceballos ML; Jenner P; Marsden CD
Neurosci Lett; 1992 Oct; 145(2):171-4. PubMed ID: 1281532
[TBL] [Abstract][Full Text] [Related]
33. Brain neuropeptides in progressive supranuclear palsy.
Taquet H; Javoy-Agid F; Mauborgne A; Benoliel JJ; Agid Y; Legrand JC; Hamon M; Cesselin F
Brain Res; 1987 May; 411(1):178-82. PubMed ID: 2440513
[TBL] [Abstract][Full Text] [Related]
34. Effect of dopaminergic drugs on processing and degradative neuropeptidase mRNA in rat frontal cortex and caudate-putamen.
Waters SM; Rounseville MP; Davis TP
Brain Res; 1997 Apr; 754(1-2):28-34. PubMed ID: 9134956
[TBL] [Abstract][Full Text] [Related]
35. Subcutaneous formalin enhances outflow of met-enkephalin- and cholecystokinin-like materials in the rat nucleus accumbens.
Lapeyre S; Mauborgne A; Becker C; Benoliel JJ; Cesselin F; Hamon M; Bourgoin S
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):399-406. PubMed ID: 11330333
[TBL] [Abstract][Full Text] [Related]
36. Neuropeptide levels in discrete brain regions in the iminodipropionitrile-induced persistent dyskinesia rat model.
Kawada Y; Ogawa N; Asanuma M; Mori A
Regul Pept; 1995 Jan; 55(1):103-10. PubMed ID: 7536949
[TBL] [Abstract][Full Text] [Related]
37. Subchronic haloperidol administration decreases aminopeptidase N activity and [Met5]enkephalin metabolism in rat striatum and cortex.
Konkoy CS; Waters SM; Davis TP
Eur J Pharmacol; 1996 Feb; 297(1-2):47-51. PubMed ID: 8851165
[TBL] [Abstract][Full Text] [Related]
38. Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain.
Rosén A; Brodin K; Eneroth P; Brodin E
Acta Physiol Scand; 1992 Nov; 146(3):341-8. PubMed ID: 1282765
[TBL] [Abstract][Full Text] [Related]
39. Chronic exposure to hypergravity affects thyrotropin-releasing hormone levels in rat brainstem and cerebellum.
Daunton NG; Tang F; Corcoran ML; Fox RA; Man SY
Biol Signals Recept; 1998; 7(6):337-44. PubMed ID: 9873155
[TBL] [Abstract][Full Text] [Related]
40. Comparison between short- and long-term haloperidol administration on somatostatin and substance P concentrations in the rat brain.
Radke JM; MacLennan AJ; Vincent SR; Fibiger HC
Brain Res; 1988 Mar; 445(1):55-60. PubMed ID: 2452671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
